Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (49)

2024

  1. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

    European Neuropsychopharmacology, Vol. 85, pp. 66-77

2023

  1. Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study

    Biomedicines, Vol. 11, Núm. 2

  2. Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia

    The Cochrane database of systematic reviews, Vol. 7, pp. CD013511

  3. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease (Journal of Neurology, (2023), 270, 1, (519-529), 10.1007/s00415-022-11427-x)

    Journal of Neurology

  4. Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies

    Neural Computing and Applications, Vol. 35, Núm. 8, pp. 5603-5617

  5. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

    Journal of Translational Medicine, Vol. 21, Núm. 1

  6. Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases

    Neurologia, Vol. 38, Núm. 9, pp. 609-616

  7. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease

    Journal of Neurology, Vol. 270, Núm. 8, pp. 3821-3829

  8. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

  9. UD Interference Test: Creation and validation of a new instrument of resistance to interference. Normalization and standardization for Spanish population

    Neurologia, Vol. 38, Núm. 8, pp. 566-576

  10. Virtual coach and telerehabilitation for Parkinson´s disease patients: vCare system

    Journal of Public Health (Germany)

2022

  1. Author Correction: Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 (Scientific Reports, (2022), 12, 1, (7097), 10.1038/s41598-022-09771-z)

    Scientific Reports

  2. Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?

    Journal of Translational Medicine, Vol. 20, Núm. 1

  3. COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences

    Infection, Vol. 50, Núm. 1, pp. 179-189

  4. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

  5. Costs and effects of telerehabilitation in neurological and cardiological diseases: A systematic review

    Frontiers in Medicine, Vol. 9

  6. Heart-brain synchronization breakdown in Parkinson’s disease

    npj Parkinson's Disease, Vol. 8, Núm. 1

  7. Impact of Visual Impairment on Vision-Related Quality of Life in Parkinson's Disease

    Journal of Parkinson's Disease, Vol. 12, Núm. 5, pp. 1633-1643

  8. Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease

    Journal of Neurology

  9. Neuropsychological Profile of Hereditary Ataxias: Study of 38 Patients

    Archives of Clinical Neuropsychology, Vol. 37, Núm. 5, pp. 904-915